Welcome to IJSDR UGC CARE norms ugc approved journal norms IJRTI Research Journal | ISSN : 2455-2631
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.15 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Issue: August 2022

Volume 7 | Issue 8

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Development and Validation of RP-HPLC and UV-Spectrophotometric Absorptivity Method for Simultaneous Estimation of Cyclobenzaprine hydrochloride and Aceclofenac in Pharmaceutical dosage form
Authors Name: Annasaheb Sanjay Gaikwad , Monika Namdev Madibone , Jeevan R Rajguru , Prashant B Jadhav
Unique Id: IJSDR2004056
Published In: Volume 5 Issue 4, April-2020
Abstract: The objective of present research is to develop a simple, sensitive, linear, precise and accurate RP-HPLC and UV-Spectrophotometric method for simultaneous estimation of Cyclobenzaprine hydrochloride and Aceclofenac in bulk and tablet formulation as developed and validated. UV-Spectrophotometric method Calibration plot were linear R2 =0.9996 over the concentration range 1-5µg/ml for Cyclobenzaprine hydrochloride, R²= 0.9995 for the Aceclofenac 13-65µg/ml. And Chromatographic conditions used are stationary phase Inertsil ODS column (250 × 4.6 mm×5µ) (5µm particle size) the mobile phase Methanol: 10mm KH2PO4 Buffer (Ph-3) (70:30) and flow rate was maintained 0.9ml/min, detection wavelength was 220nm. The retention times were 4.7min and 2.9 min for Cyclobenzaprine hydrochloride and Aceclofenac respectively. Calibration plot were linear R2 = 0.9996 over the concentration range 3-15µg/ml for Cyclobenzaprine hydrochloride, R2 = 0.9994 for the Aceclofenac 40-200µg/ml. No interference from any component of pharmaceutical dosage form was observed. The proposed method has been validated as per ICH guidelines, validation studies revealed that method id specific, rapid, reliable and reproducible. The developed method successfully employed for routine quality control analysis in the combined pharmaceutical dosage form.
Keywords: Cyclobenzaprine hydrochloride and Aceclofenac, UV- Spectrophotometric, RP-HPLC Method.
Cite Article: "Development and Validation of RP-HPLC and UV-Spectrophotometric Absorptivity Method for Simultaneous Estimation of Cyclobenzaprine hydrochloride and Aceclofenac in Pharmaceutical dosage form", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.5, Issue 4, page no.320 - 329, April-2020, Available :http://www.ijsdr.org/papers/IJSDR2004056.pdf
Downloads: 000101775
Publication Details: Published Paper ID: IJSDR2004056
Registration ID:191659
Published In: Volume 5 Issue 4, April-2020
DOI (Digital Object Identifier):
Page No: 320 - 329
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview

Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
DOI (A digital object identifier)

Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media

Indexing Partner